@article{UBHD-68381707,
  author={Chêne, Arnaud and Leroy, Odile and Havelange, Nicolas and Viebig, Nicola},
  title={Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development},
  year={2018},
  pages={1-11},
  language={eng},
  issn={2059-0105},
  volume={3},
  number={Artikel-ID 28},
  note={Gesehen am 23.04.2019},
  journal={npj vaccines},
  doi={10.1038/s41541-018-0064-6},
}
@article{UBHD-68412178,
  author={Chêne, Arnaud and Leroy, Odile and Havelange, Nicolas and Viebig, Nicola},
  title={Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC},
  year={2019},
  pages={145-156},
  language={eng},
  issn={2352-3964},
  volume={42},
  note={Gesehen am 25.07.2019},
  journal={EBioMedicine},
  doi={10.1016/j.ebiom.2019.03.010},
}
@article{UBHD-68154424,
  author={Faber, Bart and Houard, Sophie and Havelange, Nicolas},
  title={Production, quality control, stability and pharmacotoxicity of a malaria vaccine comprising three highly similar PfAMA1 protein molecules to overcome antigenic variation},
  year={2016},
  language={eng},
  issn={1932-6203},
  volume={11(2016},
  note={Gesehen am 28.08.2017},
  journal={PLOS ONE},
  doi={10.1371/journal.pone.0164053},
}
@article{UBHD-68587702,
  author={Sirima, Sodiomon and Havelange, Nicolas and Leroy, Odile and Viebig, Nicola},
  title={PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria},
  subtitle={a first-in-human, randomised, double-blind, placebo-controlled study},
  year={2020},
  pages={585-597},
  language={eng},
  issn={1474-4457},
  volume={20},
  number={5},
  note={Gesehen am 17.06.2020},
  journal={The lancet},
  doi={10.1016/S1473-3099(19)30739-X},
}